glp-1 and macular degeneration RAs Linked to Doubled Risk for GLP-1 receptor agonists in eye

According to NICE guidance and MHRA safety information, healthcare professionals should maintain vigilance for rare but serious adverse effects including acute pancreatitis, gallbladder disease, and potential thyroid tumours (based on animal studies, though human risk remains uncertain)

The regulatory environment for compounded GLP-1 products has tightened significantly in 2026, and consumers should evaluate any telehealth platform's compliance posture within this evolving landscape

Peripherally in the gut, ghrelin was shown by us to stimulate gastric acid secretion and gastrin release (24) and to exhibit the gastro- and pancreato-protective activities against various irritants (25)

Comparative protein structure modeling using Modeller

Thrive GLP-1 requires daily multi-step administration